Sign In
Buy PFE
$26.04
+0.345 (+1.34%)
At Close: Jun 05, 2026
PFE or NVO: Which Is the Better Value Stock Right Now?
12:45pm, Wednesday, 11'th Sep 2024
Investors with an interest in Large Cap Pharmaceuticals stocks have likely encountered both Pfizer (PFE) and Novo Nordisk (NVO). But which of these two companies is the best option for those looking f
2 Beaten-Down Stocks That Could Be Great Buys on the Dip
05:30am, Wednesday, 11'th Sep 2024
Pfizer is slowly starting to replace its COVID-19 portfolio with newer medicines. Snap's strong ecosystem could allow it to eventually turn a profit and deliver strong returns.
Why Pfizer (PFE) Outpaced the Stock Market Today
06:50pm, Tuesday, 10'th Sep 2024
In the most recent trading session, Pfizer (PFE) closed at $29.74, indicating a +1.11% shift from the previous trading day.
Pfizer: The Rally May Just Be Getting Started
12:59pm, Tuesday, 10'th Sep 2024
I believe Pfizer should be rated as a "Buy" due to its strong non-COVID portfolio, cost control, promising pipeline, and current undervaluation. Recent financial performance shows 14% YoY operational
Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It
10:00am, Tuesday, 10'th Sep 2024
Recently, Zacks.com users have been paying close attention to Pfizer (PFE). This makes it worthwhile to examine what the stock has in store.
3 High-Yield Stocks to Buy Hand Over Fist in September
05:45am, Tuesday, 10'th Sep 2024
Dominion Energy should benefit if the Fed cuts interest rates. Pfizer is poised to return to growth thanks to business development deals and a strong pipeline.
Pfizer Quietly Gaining Momentum
08:30am, Monday, 09'th Sep 2024
Pfizer's RSI is trending upward, bouncing from the 50 support level, signaling potential stock strength and accumulation. Pfizer's KP.2-adapted COVID-19 vaccine received FDA approval, positioning the
Buy Low, Sell High, Get Paid To Wait (5 Easy Examples)
06:12am, Monday, 09'th Sep 2024
Buy Low, Sell High, Get Paid To Wait: Our simple investment philosophy focuses on purchasing assets at a discount to their intrinsic value. Key factors for maximizing profit include industry growth, m
3 No-Brainer Dividend Stocks With Yields Above 5% You Can Buy Now and Hold at Least a Decade
04:38am, Monday, 09'th Sep 2024
W.P. Carey has adjusted well to the shrunken need for office space following the pandemic. AT&T is adding heaps of broadband subscribers and retaining its mobile internet subscribers.
3 No-Brainer Dividend Stocks to Buy in September
07:30am, Sunday, 08'th Sep 2024
AbbVie is a Dividend King with solid growth prospects. Merck's looming patent cliff isn't as alarming as it might seem.
3 Dividend Aristocrats That Pay You More and More Money
07:28am, Sunday, 08'th Sep 2024
Smart investors are aware that growing your money without working for it can happen through the right investment strategy.
A Few Years From Now, You'll Wish You Had Bought This Undervalued Stock
05:50am, Friday, 06'th Sep 2024
Pfizer has an attractive valuation due to two key factors. The drugmaker has multiple growth drivers in its lineup and potentially more in the pipeline.
Pharma stocks analysis: Pfizer, Bristol-Myers Squibb, AbbVie
04:00am, Friday, 06'th Sep 2024
Pharmaceutical (PPH) stocks have done relatively well this year. The closely watched iShares US Pharmaceutical ETF (IHE) stock has jumped by 16.5%, slightly beating the S&P 500 index, which has risen
Why Pfizer Investors Should Closely Monitor VAX-31
04:24pm, Thursday, 05'th Sep 2024
Investing in biotech and pharma stocks is certainly not for everyone, as these companies are vulnerable to various external risks. I turned bullish on Pfizer last January based on several reasons, inc
Pfizer: Cheap For A Reason, But I Remain Bullish
08:00am, Thursday, 05'th Sep 2024
Pfizer's stock is undervalued with a 48% upside potential, supported by robust product pipelines, strategic initiatives, and a high 5.94% forward dividend yield. Recent pipeline developments, includin
